Alan Levy

Président chez Tasso, Inc.

Profil

Alan J.
Levy was the founder of Northstar Neuroscience, Inc., founded in 1999, where the title held was Chairman from 2007 to 2009.
Dr. Levy was the founder of Chrono Therapeutics, Inc., founded in 2014, where the title held was Director from 2018 to 2022.
Dr. Levy currently holds the position of Chairman at Tasso, Inc. Dr. Levy is Chairman at Salvia BioElectronics BV since 2021.
Dr. Levy is Director at Proteus Digital Health, Inc. since 2002.
Dr. Levy is Independent Director at Orthocon, Inc. Dr. Levy is Director at Abyrx, Inc. since 2013.
Dr. Levy is Executive Director at Bardy Diagnostics, Inc. Dr. Levy is Director at Proprio, Inc. Former jobs include President & Chief Executive Officer at Heartstream, Inc. from 1993 to 1998.
Chief Executive Officer & Director at Incline Therapeutics, Inc. from 2012 to 2013.
President & Chief Executive Officer at Vertis Neuroscience, Inc. Executive Chairman at BaroSense, Inc. Director at Calypso Medical Technologies, Inc. Director, VP-Research & New Business Development at Ethicon, Inc. Independent Director at Intuitive Surgical, Inc. from 2018 to 2024.
President & Chief Operating Officer at Adler Group, Inc. in 2000.
President & Chief Operating Officer at Heart Technology, Inc. in 1995.
Trustee at Seattle Biomedical Research Institute.
Senior Advisor at Frazier Management LLC from 2007 to 2017.
Education includes undergraduate studies at City University of New York and a doctorate from Purdue University.

Postes actifs de Alan Levy

Sociétés	Poste	Début
Proteus Digital Health, Inc.	Directeur/Membre du Conseil	01/09/2002
Orthocon, Inc.	Directeur/Membre du Conseil	-
Abyrx, Inc.	Directeur/Membre du Conseil	01/01/2013
Bardy Diagnostics, Inc.	Directeur/Membre du Conseil	-
eLoupes, Inc.	Directeur/Membre du Conseil	-
Salvia BioElectronics BV	Président	01/07/2021
Tasso, Inc.	Président	-

Anciens postes connus de Alan Levy

Sociétés	Poste	Fin
INTUITIVE SURGICAL, INC.	Directeur/Membre du Conseil	25/04/2024
Chrono Therapeutics, Inc.	Directeur Général	01/02/2018
░░░░░░░ ░░░░░░░░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░